{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:22:21Z","timestamp":1792801341150,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH, Florida Department of Health Ed and Ethel Moore Alzheimer\u2019s Disease Research Program","award":["R21AG065653, R01AG078615, 24A07"],"award-info":[{"award-number":["R21AG065653, R01AG078615, 24A07"]}],"id":[{"id":"https:\/\/ror.org\/03e1xkn26","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-01982-0","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:15:19Z","timestamp":1770448519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["CI-994 is a dual modulator of class I HDACs and Wnt\/\u03b2-catenin signaling for the treatment of Alzheimer's disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Wenyan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kawatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Nambara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suren","family":"Jeevaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunmi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Rodriguez","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Izhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Caroline","family":"Raulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew K.","family":"Wszolek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"10","key":"1982_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"YJ Hou","year":"2019","unstructured":"Hou YJ, Dan XL, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565\u201381.","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"1982_CR2","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT. Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nat Neurosci. 2020;23(10):1183\u201393.","journal-title":"Nat Neurosci"},{"issue":"9","key":"1982_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"1982_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd4360","volume":"13","author":"KJ Falkenberg","year":"2014","unstructured":"Falkenberg KJ, Johnstone RW. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov. 2014;13(9):673\u201391.","journal-title":"Nat Rev Drug Discov"},{"key":"1982_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.conb.2020.08.011","volume":"67","author":"AM Burns","year":"2021","unstructured":"Burns AM, Graff J. Cognitive epigenetic priming: leveraging histone acetylation for memory amelioration. Curr Opin Neurobiol. 2021;67:75\u201384.","journal-title":"Curr Opin Neurobiol"},{"issue":"7","key":"1982_CR6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1021\/acschemneuro.1c00775","volume":"13","author":"PC Pao","year":"2022","unstructured":"Pao PC, Tsai LH. Histone deacetylases 1 and 2 in memory function. ACS Chem Neurosci. 2022;13(7):848\u201358.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"1982_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","volume":"20","author":"V Kumar","year":"2022","unstructured":"Kumar V, Kundu S, Singh A, Singh S. Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective. Curr Neuropharmacol. 2022;20(1):158\u201378.","journal-title":"Curr Neuropharmacol"},{"key":"1982_CR8","doi-asserted-by":"publisher","first-page":"1025473","DOI":"10.3389\/fnagi.2022.1025473","volume":"14","author":"F Kabir","year":"2022","unstructured":"Kabir F, Atkinson R, Cook AL, Phipps AJ, King AE. The role of altered protein acetylation in neurodegenerative disease. Front Aging Neurosci. 2022;14:1025473.","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"1982_CR9","doi-asserted-by":"publisher","first-page":"e13895","DOI":"10.1111\/acel.13895","volume":"22","author":"D Marinho","year":"2023","unstructured":"Marinho D, Ferreira IL, Lorenzoni R, Cardoso SM, Santana I, Rego AC. Reduction of class I histone deacetylases ameliorates ER-mitochondria cross-talk in Alzheimer\u2019s disease. Aging Cell. 2023;22(8):e13895.","journal-title":"Aging Cell"},{"issue":"4","key":"1982_CR10","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/npp.2009.197","volume":"35","author":"M Kilgore","year":"2010","unstructured":"Kilgore M, Miller CA, Fass DM, Hennig KM, Haggarty SJ, Sweatt JD, et al. Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology. 2010;35(4):870\u201380.","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"1982_CR11","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1038\/npp.2015.93","volume":"40","author":"G Rumbaugh","year":"2015","unstructured":"Rumbaugh G, Sillivan SE, Ozkan ED, Rojas CS, Hubbs CR, Aceti M, et al. Pharmacological selectivity within class I histone deacetylases predicts effects on synaptic function and memory rescue. Neuropsychopharmacology. 2015;40(10):2307\u201316.","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"1982_CR12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrm3470","volume":"13","author":"C Niehrs","year":"2012","unstructured":"Niehrs C. The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol. 2012;13(12):767\u201379.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"1982_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985\u201399.","journal-title":"Cell"},{"issue":"1","key":"1982_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13041-019-0525-5","volume":"12","author":"L Jia","year":"2019","unstructured":"Jia L, Pina-Crespo J, Li Y. Restoring Wnt\/beta-catenin signaling is a promising therapeutic strategy for Alzheimer\u2019s disease. Mol Brain. 2019;12(1):104.","journal-title":"Mol Brain"},{"issue":"12","key":"1982_CR15","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1111\/bcp.14889","volume":"87","author":"AD Bondarev","year":"2021","unstructured":"Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV, Schioth HB. Recent developments of HDAC inhibitors: emerging indications and novel molecules. Br J Clin Pharmacol. 2021;87(12):4577\u201397.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1982_CR16","first-page":"994","volume":"6","author":"L Riva","year":"2000","unstructured":"Riva L, Blaney SM, Dauser R, Nuchtern JG, Durfee J, McGuffey L, et al. Pharmacokinetics and cerebrospinal fluid penetration of CI-994 (N-acetyldinaline) in the nonhuman primate. Clin Cancer Res. 2000;6(3):994\u20137.","journal-title":"Clin Cancer Res"},{"issue":"1\u20132","key":"1982_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cell.2013.12.020","volume":"156","author":"J Graff","year":"2014","unstructured":"Graff J, Joseph NF, Horn ME, Samiei A, Meng J, Seo J, et al. Epigenetic priming of memory updating during reconsolidation to attenuate remote fear memories. Cell. 2014;156(1\u20132):261\u201376.","journal-title":"Cell"},{"issue":"7","key":"1982_CR18","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/annonc\/mdl081","volume":"17","author":"DA Richards","year":"2006","unstructured":"Richards DA, Boehm KA, Waterhouse DM, Wagener DJ, Krishnamurthi SS, Rosemurgy A, et al. Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study. Ann Oncol. 2006;17(7):1096\u2013102.","journal-title":"Ann Oncol"},{"issue":"1","key":"1982_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.critrevonc.2008.03.002","volume":"68","author":"C Gridelli","year":"2008","unstructured":"Gridelli C, Rossi A, Maione P. The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer. Crit Rev Oncol Hematol. 2008;68(1):29\u201336.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1982_CR20","doi-asserted-by":"crossref","unstructured":"Avendano C, Menende TC. Chapter 8 - Epigenetic therapy of cancer. Medicinal Chemistry of Anticancer Drugs (Third Edition). 2023.","DOI":"10.1016\/B978-0-12-818549-0.00019-4"},{"issue":"5","key":"1982_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41419-018-0543-8","volume":"9","author":"S Zhang","year":"2018","unstructured":"Zhang S, Fujita Y, Matsuzaki R, Yamashita T. Class I histone deacetylase (HDAC) inhibitor CI-994 promotes functional recovery following spinal cord injury. Cell Death Dis. 2018;9(5):460.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1982_CR22","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41467-019-13918-4","volume":"11","author":"A Cooper","year":"2020","unstructured":"Cooper A, Butto T, Hammer N, Jagannath S, Fend-Guella DL, Akhtar J, et al. Inhibition of histone deacetylation rescues phenotype in a mouse model of Birk-Barel intellectual disability syndrome. Nat Commun. 2020;11(1):480.","journal-title":"Nat Commun"},{"key":"1982_CR23","doi-asserted-by":"publisher","first-page":"674745","DOI":"10.3389\/fnins.2021.674745","volume":"15","author":"B McClarty","year":"2021","unstructured":"McClarty B, Rodriguez G, Dong H. Dose effects of histone deacetylase inhibitor tacedinaline (CI-994) on antipsychotic haloperidol-induced motor and memory side effects in aged mice. Front Neurosci. 2021;15:674745.","journal-title":"Front Neurosci"},{"issue":"22","key":"1982_CR24","doi-asserted-by":"publisher","first-page":"e2116797119","DOI":"10.1073\/pnas.2116797119","volume":"119","author":"AM Burns","year":"2022","unstructured":"Burns AM, Farinelli-Scharly M, Hugues-Ascery S, Sanchez-Mut JV, Santoni G, Graff J. The HDAC inhibitor CI-994 acts as a molecular memory aid by facilitating synaptic and intracellular communication after learning. Proc Natl Acad Sci U S A. 2022;119(22):e2116797119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"56","key":"1982_CR25","doi-asserted-by":"publisher","first-page":"9129","DOI":"10.1038\/sj.onc.1208123","volume":"23","author":"Y Li","year":"2004","unstructured":"Li Y, Lu W, He X, Schwartz AL, Bu G. LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering beta-catenin subcellular distribution. Oncogene. 2004;23(56):9129\u201335.","journal-title":"Oncogene"},{"issue":"19","key":"1982_CR26","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1016\/j.febslet.2011.08.046","volume":"585","author":"C Lin","year":"2011","unstructured":"Lin C, Lu W, Zhai L, Bethea T, Berry K, Qu Z, et al. Mesd is a general inhibitor of different Wnt ligands in Wnt\/LRP signaling and inhibits PC-3 tumor growth in vivo. FEBS Lett. 2011;585(19):3120\u20135.","journal-title":"FEBS Lett"},{"issue":"12","key":"1982_CR27","doi-asserted-by":"publisher","first-page":"e29290","DOI":"10.1371\/journal.pone.0029290","volume":"6","author":"W Lu","year":"2011","unstructured":"Lu W, Lin C, Roberts MJ, Waud WR, Piazza GA, Li Y. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt\/beta-catenin pathway. PLoS ONE. 2011;6(12):e29290.","journal-title":"PLoS ONE"},{"issue":"1","key":"1982_CR28","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao J, Fu Y, Yamazaki Y, Ren Y, Davis MD, Liu CC, et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids. Nat Commun. 2020;11(1):5540.","journal-title":"Nat Commun"},{"issue":"5","key":"1982_CR29","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00401-021-02361-9","volume":"142","author":"J Zhao","year":"2021","unstructured":"Zhao J, Lu W, Ren Y, Fu Y, Martens YA, Shue F, et al. Apolipoprotein E regulates lipid metabolism and alpha-synuclein pathology in human iPSC-derived cerebral organoids. Acta Neuropathol. 2021;142(5):807\u201325.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1982_CR30","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41380-023-02372-w","volume":"29","author":"K Kawatani","year":"2024","unstructured":"Kawatani K, Holm ML, Starling SC, Martens YA, Zhao J, Lu W, et al. ABCA7 deficiency causes neuronal dysregulation by altering mitochondrial lipid metabolism. Mol Psychiatry. 2024;29(3):809\u201319.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1982_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3233\/JAD-230218","volume":"95","author":"JR Macyczko","year":"2023","unstructured":"Macyczko JR, Wang N, Lu W, Jeevaratnam S, Shue F, Martens Y, et al. Upregulation of sFRP1 is more profound in female than male 5xFAD mice and positively associated with amyloid pathology. J Alzheimers Dis. 2023;95(2):399\u2013405.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1982_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12035-022-03065-1","volume":"60","author":"JR Macyczko","year":"2023","unstructured":"Macyczko JR, Wang N, Zhao J, Ren Y, Lu W, Ikezu TC, et al. Suppression of Wnt\/beta-catenin signaling is associated with downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer\u2019s disease. Mol Neurobiol. 2023;60(1):26\u201335.","journal-title":"Mol Neurobiol"},{"key":"1982_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1471-2105-15-224","volume":"15","author":"KR Kalari","year":"2014","unstructured":"Kalari KR, Nair AA, Bhavsar JD, O\u2019Brien DR, Davila JI, Bockol MA, et al. MAP-RSeq: Mayo Analysis Pipeline for RNA sequencing. BMC Bioinformatics. 2014;15:224.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"1982_CR34","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/biostatistics\/kxr054","volume":"13","author":"KD Hansen","year":"2012","unstructured":"Hansen KD, Irizarry RA, Wu Z. Removing technical variability in RNA-seq data using conditional quantile normalization. Biostatistics. 2012;13(2):204\u201316.","journal-title":"Biostatistics"},{"issue":"1","key":"1982_CR35","doi-asserted-by":"publisher","first-page":"20560","DOI":"10.1038\/s41598-020-76603-3","volume":"10","author":"J Goedhart","year":"2020","unstructured":"Goedhart J, Luijsterburg MS. VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots. Sci Rep. 2020;10(1):20560.","journal-title":"Sci Rep"},{"issue":"4","key":"1982_CR36","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2013","unstructured":"Kr\u00e4mer A, Green J, Pollard J Jr, Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2013;30(4):523\u201330.","journal-title":"Bioinformatics"},{"issue":"4","key":"1982_CR37","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1158\/1535-7163.MCT-13-0555","volume":"13","author":"AI Londono-Joshi","year":"2014","unstructured":"Londono-Joshi AI, Arend RC, Aristizabal L, Lu W, Samant RS, Metge BJ, et al. Effect of niclosamide on basal-like breast cancers. Mol Cancer Ther. 2014;13(4):800\u201311.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1982_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ygyno.2014.04.005","volume":"134","author":"RC Arend","year":"2014","unstructured":"Arend RC, Londono-Joshi AI, Samant RS, Li Y, Conner M, Hidalgo B, et al. Inhibition of Wnt\/beta-catenin pathway by niclosamide: a therapeutic target for ovarian cancer. Gynecol Oncol. 2014;134(1):112\u201320.","journal-title":"Gynecol Oncol"},{"issue":"23","key":"1982_CR39","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.1021\/jm701079h","volume":"50","author":"OM Moradei","year":"2007","unstructured":"Moradei OM, Mallais TC, Frechette S, Paquin I, Tessier PE, Leit SM, et al. Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity. J Med Chem. 2007;50(23):5543\u20136.","journal-title":"J Med Chem"},{"issue":"1","key":"1982_CR40","first-page":"53","volume":"3","author":"KM Hennig","year":"2017","unstructured":"Hennig KM, Fass DM, Zhao WN, Sheridan SD, Fu T, Erdin S, et al. WNT\/beta-catenin pathway and epigenetic mechanisms regulate the Pitt-Hopkins syndrome and schizophrenia risk gene TCF4. Mol Neuropsychiatry. 2017;3(1):53\u201371.","journal-title":"Mol Neuropsychiatry"},{"issue":"13","key":"1982_CR41","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/anie.200462552","volume":"44","author":"J Liu","year":"2005","unstructured":"Liu J, Wu X, Mitchell B, Kintner C, Ding S, Schultz PG. A small-molecule agonist of the Wnt signaling pathway. Angew Chem Int Ed Engl. 2005;44(13):1987\u201390.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7","key":"1982_CR42","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nn.2333","volume":"12","author":"F Ye","year":"2009","unstructured":"Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, et al. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci. 2009;12(7):829\u201338.","journal-title":"Nat Neurosci"},{"issue":"1","key":"1982_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.stem.2015.05.016","volume":"17","author":"Z Wu","year":"2015","unstructured":"Wu Z, Wei D, Gao W, Xu Y, Hu Z, Ma Z, et al. TPO-induced metabolic reprogramming drives liver metastasis of colorectal cancer CD110+ tumor-initiating cells. Cell Stem Cell. 2015;17(1):47\u201359.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"1982_CR44","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1091\/mbc.e16-07-0547","volume":"28","author":"KC Masoumi","year":"2017","unstructured":"Masoumi KC, Daams R, Sime W, Siino V, Ke H, Levander F, et al. NLK-mediated phosphorylation of HDAC1 negatively regulates Wnt signaling. Mol Biol Cell. 2017;28(2):346\u201355.","journal-title":"Mol Biol Cell"},{"issue":"1","key":"1982_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s11658-021-00305-5","volume":"27","author":"H You","year":"2022","unstructured":"You H, Li Q, Kong D, Liu X, Kong F, Zheng K, et al. The interaction of canonical Wnt\/beta-catenin signaling with protein lysine acetylation. Cell Mol Biol Lett. 2022;27(1):7.","journal-title":"Cell Mol Biol Lett"},{"issue":"15","key":"1982_CR46","doi-asserted-by":"publisher","first-page":"9701","DOI":"10.1074\/jbc.M114.620872","volume":"290","author":"C Liu","year":"2015","unstructured":"Liu C, Zhang Y, Li J, Wang Y, Ren F, Zhou Y, et al. p15RS\/RPRD1A (p15INK4b-related sequence\/regulation of nuclear pre-mRNA domain-containing protein 1A) interacts with HDAC2 in inhibition of the Wnt\/beta-catenin signaling pathway. J Biol Chem. 2015;290(15):9701\u201313.","journal-title":"J Biol Chem"},{"issue":"18","key":"1982_CR47","doi-asserted-by":"publisher","first-page":"6882","DOI":"10.1128\/MCB.20.18.6882-6890.2000","volume":"20","author":"AN Billin","year":"2000","unstructured":"Billin AN, Thirlwell H, Ayer DE. Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator. Mol Cell Biol. 2000;20(18):6882\u201390.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"1982_CR48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1074-5521(03)00093-0","volume":"10","author":"KM Koeller","year":"2003","unstructured":"Koeller KM, Haggarty SJ, Perkins BD, Leykin I, Wong JC, Kao MC, et al. Chemical genetic modifier screens: small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylation. Chem Biol. 2003;10(5):397\u2013410.","journal-title":"Chem Biol"},{"issue":"1","key":"1982_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13195-020-00746-8","volume":"13","author":"Q Su","year":"2021","unstructured":"Su Q, Li T, He PF, Lu XC, Yu Q, Gao QC, et al. Trichostatin A ameliorates Alzheimer\u2019s disease-related pathology and cognitive deficits by increasing albumin expression and Abeta clearance in APP\/PS1 mice. Alzheimers Res Ther. 2021;13(1):7.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1982_CR50","doi-asserted-by":"publisher","first-page":"15226","DOI":"10.1038\/s41598-018-33149-9","volume":"8","author":"J Behera","year":"2018","unstructured":"Behera J, Kelly KE, Voor MJ, Metreveli N, Tyagi SC, Tyagi N. Hydrogen sulfide promotes bone homeostasis by balancing inflammatory cytokine signaling in CBS-deficient mice through an epigenetic mechanism. Sci Rep. 2018;8(1):15226.","journal-title":"Sci Rep"},{"key":"1982_CR51","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.brainres.2015.10.005","volume":"1656","author":"SE Sullivan","year":"2017","unstructured":"Sullivan SE, Young-Pearse TL. Induced pluripotent stem cells as a discovery tool for Alzheimer\u2019s disease. Brain Res. 2017;1656:98\u2013106.","journal-title":"Brain Res"},{"key":"1982_CR52","doi-asserted-by":"publisher","first-page":"146803","DOI":"10.1016\/j.brainres.2020.146803","volume":"1742","author":"S Khakipoor","year":"2020","unstructured":"Khakipoor S, Crouch EE, Mayer S. Human organoids to model the developing human neocortex in health and disease. Brain Res. 2020;1742:146803.","journal-title":"Brain Res."},{"key":"1982_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semcdb.2020.05.024","volume":"111","author":"MR Salick","year":"2021","unstructured":"Salick MR, Lubeck E, Riesselman A, Kaykas A. The future of cerebral organoids in drug discovery. Semin Cell Dev Biol. 2021;111:67\u201373.","journal-title":"Semin Cell Dev Biol"},{"issue":"9","key":"1982_CR54","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nn.2360","volume":"12","author":"T Kuwabara","year":"2009","unstructured":"Kuwabara T, Hsieh J, Muotri A, Yeo G, Warashina M, Lie DC, et al. Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis. Nat Neurosci. 2009;12(9):1097\u2013105.","journal-title":"Nat Neurosci"},{"issue":"14","key":"1982_CR55","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1523\/JNEUROSCI.1425-09.2010","volume":"30","author":"MB Wisniewska","year":"2010","unstructured":"Wisniewska MB, Misztal K, Michowski W, Szczot M, Purta E, Lesniak W, et al. LEF1\/beta-catenin complex regulates transcription of the Cav3.1 calcium channel gene (Cacna1g) in thalamic neurons of the adult brain. J Neurosci. 2010;30(14):4957\u201369.","journal-title":"J Neurosci"},{"issue":"50","key":"1982_CR56","doi-asserted-by":"publisher","first-page":"20224","DOI":"10.1073\/pnas.1314239110","volume":"110","author":"J Liu","year":"2013","unstructured":"Liu J, Pan S, Hsieh MH, Ng N, Sun F, Wang T, et al. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc Natl Acad Sci USA. 2013;110(50):20224\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1982_CR57","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3390\/biology11020316","volume":"11","author":"FP McCready","year":"2022","unstructured":"McCready FP, Gordillo-Sampedro S, Pradeepan K, Martinez-Trujillo J, Ellis J. Multielectrode arrays for functional phenotyping of neurons from induced pluripotent stem cell models of neurodevelopmental disorders. Biology. 2022;11(2):316.","journal-title":"Biology"},{"issue":"3","key":"1982_CR58","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.biopsych.2020.07.014","volume":"89","author":"H Hwang","year":"2021","unstructured":"Hwang H, Szucs MJ, Ding LJ, Allen A, Ren X, Haensgen H, et al. Neurogranin, encoded by the schizophrenia risk gene NRGN, bidirectionally modulates synaptic plasticity via calmodulin-dependent regulation of the neuronal phosphoproteome. Biol Psychiatry. 2021;89(3):256\u201369.","journal-title":"Biol Psychiatry"},{"issue":"6608","key":"1982_CR59","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/384467a0","volume":"384","author":"PT Kotzbauer","year":"1996","unstructured":"Kotzbauer PT, Lampe PA, Heuckeroth RO, Golden JP, Creedon DJ, Johnson EM Jr, et al. Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature. 1996;384(6608):467\u201370.","journal-title":"Nature"},{"issue":"1","key":"1982_CR60","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1038\/s41467-024-47468-1","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Guo Y, Broer A, Dai L, Br\u04e7er S, Yan R. Cryo-EM structure of the human Asc-1 transporter complex. Nat Commun. 2024;15(1):3036.","journal-title":"Nat Commun"},{"issue":"6","key":"1982_CR61","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41580-022-00562-y","volume":"24","author":"B Zheng","year":"2023","unstructured":"Zheng B, Tuszynski MH. Regulation of axonal regeneration after mammalian spinal cord injury. Nat Rev Mol Cell Biol. 2023;24(6):396\u2013413.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1982_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-017-0089-1","volume":"6","author":"SS Yang","year":"2017","unstructured":"Yang SS, Zhang R, Wang G, Zhang YF. The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer\u2019s disease. Transl Neurodegener. 2017;6:19.","journal-title":"Transl Neurodegener."},{"key":"1982_CR63","doi-asserted-by":"publisher","first-page":"102003","DOI":"10.1016\/j.arr.2023.102003","volume":"90","author":"D Jeremic","year":"2023","unstructured":"Jeremic D, Jimenez-Diaz L, Navarro-Lopez JD. Targeting epigenetics: a novel promise for Alzheimer\u2019s disease treatment. Ageing Res Rev. 2023;90:102003.","journal-title":"Ageing Res Rev"},{"issue":"9","key":"1982_CR64","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/nn.2385","volume":"12","author":"Z Gao","year":"2009","unstructured":"Gao Z, Ure K, Ables JL, Lagace DC, Nave KA, Goebbels S, et al. Neurod1 is essential for the survival and maturation of adult-born neurons. Nat Neurosci. 2009;12(9):1090\u20132.","journal-title":"Nat Neurosci"},{"issue":"2","key":"1982_CR65","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.celrep.2014.12.015","volume":"10","author":"AM Alazami","year":"2015","unstructured":"Alazami AM, Patel N, Shamseldin HE, Anazi S, Al-Dosari MS, Alzahrani F, et al. Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families. Cell Rep. 2015;10(2):148\u201361.","journal-title":"Cell Rep"},{"issue":"7906","key":"1982_CR66","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-022-04556-w","volume":"604","author":"T Singh","year":"2022","unstructured":"Singh T, Poterba T, Curtis D, Akil H, Al Eissa M, Barchas JD, et al. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature. 2022;604(7906):509\u201316.","journal-title":"Nature"},{"issue":"24","key":"1982_CR67","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1016\/j.neuron.2024.09.020","volume":"112","author":"JI Kim","year":"2024","unstructured":"Kim JI, Miura Y, Li MY, Revah O, Selvaraj S, Birey F, Meng X, Thete MV, Pavlov SD, Andersen J, et al. Human assembloids reveal the consequences of CACNA1G gene variants in the thalamocortical pathway. Neuron. 2024;112(24):4048-4059.e7.","journal-title":"Neuron"},{"key":"1982_CR68","doi-asserted-by":"publisher","first-page":"105991","DOI":"10.1016\/j.nbd.2023.105991","volume":"177","author":"T Saunders","year":"2023","unstructured":"Saunders T, Gunn C, Blennow K, Kvartsberg H, Zetterberg H, Shenkin SD, et al. Neurogranin in Alzheimer\u2019s disease and ageing: a human post-mortem study. Neurobiol Dis. 2023;177:105991.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1982_CR69","doi-asserted-by":"publisher","first-page":"e12444","DOI":"10.1002\/trc2.12444","volume":"10","author":"RT Vontell","year":"2024","unstructured":"Vontell RT, Gober R, Dallmeier J, Brzostowicki D, Barreda A, Blennow K, et al. Association of region-specific hippocampal reduction of neurogranin with inflammasome proteins in post mortem brains of Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions. 2024;10(1):e12444.","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"issue":"6","key":"1982_CR70","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41419-024-06815-2","volume":"15","author":"KL Hole","year":"2024","unstructured":"Hole KL, Zhu B, Huggon L, Brown JT, Mason JM, Williams RJ. Tau(P301L) disengages from the proteosome core complex and neurogranin coincident with enhanced neuronal network excitability. Cell Death Dis. 2024;15(6):429.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1982_CR71","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12967-024-05008-x","volume":"22","author":"N Jagadeesan","year":"2024","unstructured":"Jagadeesan N, Roules GC, Chandrashekar DV, Yang J, Kolluru S, Sumbria RK. Modulation of hippocampal protein expression by a brain penetrant biologic TNF-alpha inhibitor in the 3xTg Alzheimer\u2019s disease mice. J Transl Med. 2024;22(1):291.","journal-title":"J Transl Med"},{"issue":"1","key":"1982_CR72","doi-asserted-by":"publisher","first-page":"e12162","DOI":"10.1002\/trc2.12162","volume":"7","author":"X Sun","year":"2021","unstructured":"Sun X, Wang Q, Blennow K, Zetterberg H, McCarthy M, Loewenstein DA, et al. Association of neurogranin gene expression with Alzheimer\u2019s disease pathology in the perirhinal cortex. Alzheimers Dement (N Y). 2021;7(1):e12162.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"13","key":"1982_CR73","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1523\/JNEUROSCI.18-13-04929.1998","volume":"18","author":"BA Horger","year":"1998","unstructured":"Horger BA, Nishimura MC, Armanini MP, Wang LC, Poulsen KT, Rosenblad C, et al. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J Neurosci. 1998;18(13):4929\u201337.","journal-title":"J Neurosci"},{"issue":"1","key":"1982_CR74","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.expneurol.2005.03.006","volume":"195","author":"L Fjord-Larsen","year":"2005","unstructured":"Fjord-Larsen L, Johansen JL, Kusk P, Tornoe J, Gronborg M, Rosenblad C, et al. Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct. Exp Neurol. 2005;195(1):49\u201360.","journal-title":"Exp Neurol"},{"issue":"3","key":"1982_CR75","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/brain\/awaa020","volume":"143","author":"Y Chu","year":"2020","unstructured":"Chu Y, Bartus RT, Manfredsson FP, Olanow CW, Kordower JH. Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson\u2019s disease. Brain. 2020;143(3):960\u201375.","journal-title":"Brain"},{"issue":"5","key":"1982_CR76","doi-asserted-by":"publisher","first-page":"590","DOI":"10.15252\/embr.201439561","volume":"16","author":"H Safory","year":"2015","unstructured":"Safory H, Neame S, Shulman Y, Zubedat S, Radzishevsky I, Rosenberg D, et al. The alanine-serine-cysteine-1 (Asc-1) transporter controls glycine levels in the brain and is required for glycinergic inhibitory transmission. EMBO Rep. 2015;16(5):590\u20138.","journal-title":"EMBO Rep"},{"issue":"11","key":"1982_CR77","doi-asserted-by":"publisher","first-page":"ENEURO.0263-23.","DOI":"10.1523\/ENEURO.0263-23.2023","volume":"10","author":"P Drehmann","year":"2023","unstructured":"Drehmann P, Milanos S, Schaefer N, Kasaragod VB, Herterich S, Holzbach-Eberle U, Harvey RJ, Villmann C. Dual role of dysfunctional Asc-1 transporter in distinct human pathologies, human startle disease, and developmental delay. eNeuro. 2023;10(11):ENEURO.0263-23.2023.","journal-title":"eNeuro"},{"issue":"6","key":"1982_CR78","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41593-020-0635-5","volume":"23","author":"AP Wingo","year":"2020","unstructured":"Wingo AP, Fan W, Duong DM, Gerasimov ES, Dammer EB, Liu Y, et al. Shared proteomic effects of cerebral atherosclerosis and Alzheimer\u2019s disease on the human brain. Nat Neurosci. 2020;23(6):696\u2013700.","journal-title":"Nat Neurosci"},{"issue":"1","key":"1982_CR79","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41467-019-09613-z","volume":"10","author":"AP Wingo","year":"2019","unstructured":"Wingo AP, Dammer EB, Breen MS, Logsdon BA, Duong DM, Troncosco JC, et al. Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age. Nat Commun. 2019;10(1):1619.","journal-title":"Nat Commun"},{"issue":"12","key":"1982_CR80","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41582-020-0397-4","volume":"16","author":"C Ballard","year":"2020","unstructured":"Ballard C, Aarsland D, Cummings J, O\u2019Brien J, Mills R, Molinuevo JL, et al. Drug repositioning and repurposing for Alzheimer disease. Nat Rev Neurol. 2020;16(12):661\u201373.","journal-title":"Nat Rev Neurol"},{"issue":"6889","key":"1982_CR81","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nature756","volume":"417","author":"B Mao","year":"2002","unstructured":"Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, et al. Kremen proteins are Dickkopf receptors that regulate Wnt\/beta-catenin signalling. Nature. 2002;417(6889):664\u20137.","journal-title":"Nature"},{"issue":"4","key":"1982_CR82","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1101\/gad.235473.113","volume":"28","author":"W de Lau","year":"2014","unstructured":"de Lau W, Peng WC, Gros P, Clevers H. The R-spondin\/Lgr5\/Rnf43 module: regulator of Wnt signal strength. Genes Dev. 2014;28(4):305\u201316.","journal-title":"Genes Dev"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-01982-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01982-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01982-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:06:19Z","timestamp":1773151579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-01982-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1982"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-01982-0","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human skin biopsies for generating iPSC lines were obtained from Mayo Clinic patients under IRB protocol with patient consent for research, which was approved by the Mayo Clinic Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Z.K.W. is partially supported by the NIH\/NIA and NIH\/NINDS (1U19AG063911, FAIN: U19AG063911), the Haworth Family Professorship in Neurodegenerative Diseases fund, The Albertson Parkinson's Research Foundation, PPND Family Foundation, and Margaret N. and John Wilchek Family. He serves as PI or Co-PI on Biohaven Pharmaceuticals, Inc. (BHV4157-206), Vigil Neuroscience, Inc. (VGL101-01.002, VGL101-01.201, Csf1r biomarker and repository project, and ultra-high field MRI in the diagnosis and management of CSF1R-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia), ONO-2808\u201303, and Amylyx AMX0035-009 projects\/grants. He serves as Co-PI of the Mayo Clinic APDA Center for Advanced Research and as an external advisory board member for the Vigil Neuroscience, Inc., and as a consultant for Eli Lilly & Company. G.B. consults for SciNeuro Pharmaceuticals. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}